
Vincent Gallet
Journalist
LSEG, Deutsche Bank's new "primus inter pares"
London Stock Exchange Group (LSEG) is up 1.2% at 9,870 pence in London, against the backdrop of positive comments from Deutsche Bank, which has made the British group its new "primus inter pares" among European exchange operators.
17 November 2026 at 01:18 am AEDT
Uber launches Zoox autonomous robotaxi service in Las Vegas
Uber Technologies and Zoox announce that Zoox's fully autonomous robotaxis are now available through the Uber app in Las Vegas. Zoox's first partnership with a third-party platform such as Uber, the service gives users a new transportation option for getting around the city.
17 November 2026 at 01:17 am AEDT

Wolters Kluwer acquires AgileMD
Wolters Kluwer shares were pretty steady at around EUR91 in Amsterdam today, after announcing that it had reached an agreement to acquire US-based AgileMD for up to $100m on Friday evening, including $40m payable upon completion of the transaction and the balance in the form of deferred payments contingent on the achievement of performance targets.
16 November 2026 at 09:40 pm AEDT
Banco Sabadell share slips after recommendation downgrade
Banco Sabadell shares fell 0.4% to EUR3.73 in early trading in Madrid, penalized by Deutsche Bank's downgrade of its recommendation from "buy" to "hold", while raising its price target from EUR3.75 to EUR3.85, as part of a note on Spanish and Portuguese banks.
16 November 2026 at 09:40 pm AEDT

SES contributes to digital inclusion in African schools
Satellite operator SES announces progress on its commitment to the International Telecommunication Union's (ITU) Partner2Connect digital coalition, which plans to connect 30 schools in Malawi, Burundi, Zambia and Zimbabwe by the end of 2026.
16 November 2026 at 08:40 pm AEDT

FDA gives Roche green light for PMN
Roche has said the US Food and Drug Administration has approved Gazyva/Gazyvaro (obinutuzumab) to treat adult patients with primary membranous nephropathy (PMN) who are at risk of disease progression, to induce proteinuria remission.
16 November 2026 at 08:11 pm AEDT

Encouraging data for CagriSema (Novo Nordisk) in obesity
Novo Nordisk reported results, presented at the ObesityWeek 2026 congress in Washington, from two post hoc analyses of the phase 3 REDEFINE 1 trial evaluating CagriSema 2.4 mg / 2.4 mg, an investigational fixed-dose combination of cagrilintide and semaglutide in adults who are overweight or living with obesity.
16 November 2026 at 08:10 pm AEDT
Exosens secures firm order for 25,000 image intensifier tubes
Exosens said it has recorded a firm order for the supply of 25,000 high-performance 4G+ image intensifier tubes, intended to be integrated into Theon Sensors' night vision products to support the company in equipping its European customers.
16 November 2026 at 05:46 pm AEDT
Nokia selected for Department of War program
Nokia has announced that it has won a contract under the RAPID project of the US Department of War (DoW), led by the FutureG office, to develop and demonstrate integrated technologies using 5G and 6G infrastructure to detect and track objects, including drones.
14 November 2026 at 02:25 am AEDT
Engie and Google consider partnership in Châteauroux
Engie and Google announced that they have signed a memorandum of understanding under which the energy group could become the technology giant's preferred partner for supplying and managing the energy needed for its planned data center project near Châteauroux, subject to the conclusion of subsequent agreements.
13 November 2026 at 10:07 pm AEDT
Confident in its targets, Aviva shares climb after trading update
Aviva shares are up 3%, at 762 pence, in London, following the British insurance company's trading update for the period ended September, in which it expressed confidence in achieving its targets for FY 2026 and beyond.
13 November 2026 at 09:33 pm AEDT
Generali overlooked despite better-than-expected earnings
Generali shares are down 1.4% to EUR44.4, underperforming the FTSE MIB (-0.2%) in Milan after the insurance company released its nine-month results. Although it posted slightly better-than-expected net profit, Jefferies described the performance as "less encouraging than it appears."
13 November 2026 at 09:02 pm AEDT
Richemont improves profitability in H1
Richemont has reported H1 EPS of EUR4.29, ended in late September, compared with EUR3.08 for the same period a year earlier, as well as a 1/3 increase in operating profit to EUR3.129bn, representing a 3.3-point improvement in its margin to 25.5%.
13 November 2026 at 08:01 pm AEDT

Applied Materials' EPS Nearly Doubles in 4th Quarter
Applied Materials has reported Q4 2025-2026 non-GAAP EPS that is up 92% at $4.16, largely in line with consensus of $4.18, with its non-GAAP operating margin improving 6.7 points, to 35.3%.
13 November 2026 at 08:00 pm AEDT

IDI increases NAV per share by nearly 8% over nine months
Investment firm IDI reported a revalued net asset value (NAV) per share of €101.54 as of September 30, 2026, up 7.8% from December 31, 2025 (€94.20 after the dividend), noting that only liquid assets and listed securities were revalued in the third quarter.
13 November 2026 at 07:24 pm AEDT

EPC Group boosts sales by more than 14% over nine months
EPC Group (Explosives and Chemicals) reported consolidated revenue from operations, including joint ventures, up 14.4% in the first nine months of 2026, or 14.6% at constant exchange rates and on a like-for-like basis, reaching €498.0m at the end of September 2026.
13 November 2026 at 05:50 pm AEDT
AdVini in negotiations to acquire two wine brands
AdVini and Vinadeis by InVivo announced that they have entered into exclusive negotiations regarding a proposed acquisition by AdVini of the Bonne Nouvelle and Mythique brands, which together represent annual revenue of approximately €14m.
13 November 2026 at 05:14 pm AEDT
Discover our authors
Chief Editor
Journalist
Journalist
Junior Analyst
Journalist
- Stock Market
- Our authors
- Vincent Gallet

















